000 01316 a2200277 4500
005 20250518080340.0
264 0 _c20200629
008 202006s 0 0 eng d
022 _a1878-7533
024 7 _a10.1016/j.soard.2019.12.005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBaldwin, Dustin
245 0 0 _aResponse to letter to editor entitled: Improvement of nonalcoholic fatty liver disease in ALT at ≥12 months after Roux-en-Y gastric bypass and sleeve gastrectomy, no effect in ALT and AST at <12 months after SG and in AST at >12 and ≤24 months after RYGB by Wang et al.
_h[electronic resource]
260 _bSurgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
_c03 2020
300 _a450-451 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aGastrectomy
650 0 4 _aGastric Bypass
650 0 4 _aHumans
650 0 4 _aLaparoscopy
650 0 4 _aNon-alcoholic Fatty Liver Disease
650 0 4 _aObesity, Morbid
_xsurgery
700 1 _aGangemi, Antonio
773 0 _tSurgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
_gvol. 16
_gno. 3
_gp. 450-451
856 4 0 _uhttps://doi.org/10.1016/j.soard.2019.12.005
_zAvailable from publisher's website
999 _c30492880
_d30492880